News

Jasper Therapeutics Gears Up for Major Investor Engagement Events

Jasper Therapeutics Gears Up for Major Investor Engagement Events

Jasper Therapeutics Gears Up for Major Investor Engagement Events

Jasper Therapeutics, Inc. (Nasdaq: JSPR), a pioneering clinical-stage biotechnology company, is excited to announce its participation in two important investor conferences this September. The company is dedicated to developing briquilimab, a novel therapy that targets KIT (CD117) to address diseases driven by mast cells, including chronic spontaneous urticaria and asthma.

Upcoming Conferences

Cantor Fitzgerald Global Healthcare Conference 2025

Jasper will present at the Cantor Fitzgerald Global Healthcare Conference 2025, scheduled for September 3-5. Management will engage with investors through a fireside chat on Wednesday, September 3, at 1:00 PM EDT.

H.C. Wainwright 27th Annual Global Investment Conference

Following the Cantor Fitzgerald Conference, Jasper will participate in the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10. The company’s fireside chat is set for Tuesday, September 9, at 3:00 PM EDT.

Accessing the Presentations

Live webcasts of the fireside chats will be available through the News & Events section on Jasper's Investor Relations website. Additionally, archived recordings of the presentations will be accessible for 30 days after the live events.

About Jasper Therapeutics

Jasper Therapeutics is at the forefront of innovation in the biotechnology sector, particularly in treating chronic mast cell diseases. At the core of its approach is briquilimab, a targeted monoclonal antibody designed to block the stem cell factor from binding to the KIT receptor on mast cells. This groundbreaking therapy has shown promising efficacy and safety in clinical trials for conditions such as chronic spontaneous urticaria and chronic inducible urticaria.

The Potential of Briquilimab

Briquilimab's distinct mechanism of action provides significant therapeutic potential. By inhibiting signaling through the KIT receptor, it disrupts the survival signals for mast cells, guiding them towards apoptosis. This process effectively reduces excessive mast cell activity, which is crucial for alleviating the inflammatory responses associated with various mast cell-driven disorders. Clinical studies are currently underway to establish the full therapeutic profile of briquilimab.

Connect with Jasper Therapeutics

For more information about Jasper Therapeutics and its innovative approach to chronic mast cell diseases, visit www.jaspertx.com.

Frequently Asked Questions

What is jasper Therapeutics focused on?

Jasper Therapeutics is focused on developing briquilimab, a treatment for mast cell-driven diseases such as chronic spontaneous urticaria and asthma.

When will the investor conferences take place?

The Cantor Fitzgerald Global Healthcare Conference is on September 3-5, and the H.C. Wainwright Conference is on September 8-10.

How can I access the presentations?

You can access live webcasts of the presentations through the Investor Relations page on Jasper's website.

What is briquilimab?

Briquilimab is a targeted monoclonal antibody that blocks signals from the stem cell factor to reduce mast cell activity.

What are the potential benefits of briquilimab?

The therapy aims to alleviate symptoms associated with mast cell-driven diseases by disrupting the survival signals of mast cells.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 392

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 414

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 472

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 267

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 281

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 217

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 250

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 379

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading

Top 5 Most Recently Viewed Articles

Atlanta Hartsfield-Jackson Reigns as Top Global Airport

Updated Category News Views 445

Atlanta Hartsfield-Jackson Airport Maintains Its Prestige Atlanta Hartsfield-Jackson International Airport (ATL) has once again secured its position as the busiest airport globally, boasting a remarkable 62.7 million seats in 2024. This data, recently revealed by OAG, underscores ATL's dominance in the aviation sector, making it the hub for millions of travelers annually....

Continue Reading
Flanigan's Enterprises Achieves Significant Revenue Growth

Updated Category News Views 277

Flanigan's Enterprises Reports Robust Earnings Flanigan's Enterprises, Inc., the proud owners and operators of the renowned "Flanigan's Seafood Bar and Grill" restaurants and "Big Daddy's" retail liquor stores, has revealed impressive results for the 52 weeks ending with a notable increase in earnings. The company, recognized in the market as a major player, has...

Continue Reading
Understanding Motorola Solutions Inc Short Interest Trends

Updated Category News Views 243

Current Trends in Short Interest for Motorola Solutions Inc Motorola Solutions Inc (NYSE: MSI) has witnessed a notable increase in its short interest, which has risen by 5.95% according to the latest exchange data. This spike translates to approximately 2.59 million shares being sold short, representing 1.78% of the total shares available for trading. An interesting...

Continue Reading
S&P 500: Charting the Path Toward Record Highs

Updated Category News Views 211

S&P 500: Charting the Path Toward Record Highs Happy New Year to all readers! We are excited to delve into the potential of the S&P 500 and its journey towards new peaks. Our primary tool for financial forecasting is the Elliott Wave Principle (EWP), which has consistently proven effective. This method provides a framework to understand market movements, and our track...

Continue Reading
Gentoo Media Reports Q1 2025 Results Focused on Future Growth

Updated Category News Views 187

Gentoo Media's Comprehensive Q1 2025 Results Overview Gentoo Media has announced its interim results for the first quarter of 2025. This quarter has proven to be a pivotal moment for the company as it navigated various market challenges, all while making significant strides in its strategic focus and long-term resilience. The decisions taken during this time are expected...

Continue Reading